GreyMatter
Overview
GreyMatter is a long-term oriented investment firm that seeks to acquire and operate a single B2B software business with $2-10 million in revenue. The firm targets established, profitable or near-profitable companies in the United States or Canada. It is structured similarly to a search fund, where the principal, A.J. Rich, will take an active leadership role in the acquired company.
Portfolio Companies
4
Website
greymattercapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Blackbird Health | Jan 2024 | Series A | Co-investor |
| Vanna Health | Jan 2023 | Series A | Co-investor |
| Coral Care | Sep 2024 | Seed | Co-investor |
| Nema Health | Jan 2025 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is GreyMatter based?
GreyMatter is headquartered in Boston, Massachusetts, United States.
When was GreyMatter founded?
Founding year information for GreyMatter is not publicly available.
How many portfolio companies does GreyMatter have?
GreyMatter has 4 portfolio companies in Caplight's dataset.
What are some companies in GreyMatter's portfolio?
Portfolio companies visible on Caplight include Blackbird Health, Vanna Health, Coral Care, Nema Health.
What was GreyMatter's most recent investment shown here?
GreyMatter's most recent investment in this portfolio sample was in Nema Health in 2025.
What sectors does GreyMatter focus on?
GreyMatter focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software.
What company stages does GreyMatter focus on?
GreyMatter typically invests at the Early stage.
What is GreyMatter's AUM?
GreyMatter's assets under management are estimated at up to $25.0M.